Your browser doesn't support javascript.
loading
French consensus procedure for neuropsychological assessment in multiple sclerosis.
Jougleux, C; Joly, H; Brissard, H; Lenne, B; François, S; Hamelin, F; Derache, N; Morin, J; Reuter, F; Colamarino, R; Ruet, A.
Afiliação
  • Jougleux C; Service de neurologie et pathologies neuro-inflammatoires, Clinique neurologique, CRC SEP, CHU de Lille, Lille, France. Electronic address: caroline.jougleux@chu-lille.fr.
  • Joly H; Service de neurologie, CHU Pasteur 2, CRC SEP, Nice, France; UR2CA-URRIS, université Nice Côte d'Azur, Nice, France; CNRS, IMoPA, université de Lorraine, Nancy, France.
  • Brissard H; CNRS, IMoPA, université de Lorraine, Nancy, France; Service de neurologie, CHRU de Nancy, Nancy, France.
  • Lenne B; Groupement des hôpitaux de l'institut catholique de Lille (GHICL), Neurology Department, Lille, France.
  • François S; Service de neurologie, CHU de Nantes, Nantes, France.
  • Hamelin F; Structure régionale NeuroSEP Synapse, Le Vésinet, France.
  • Derache N; Department of Neurology, centre hospitalier universitaire de Caen Normandie, Caen, France.
  • Morin J; Service de neurologie pathologie inflammatoire du système nerveux central, CRC SEP, CHU Pellegrin, CHU de Bordeaux, Bordeaux, France.
  • Reuter F; Service de neurologie, hôpital de la Timone, AP-HM, pôle de neurosciences cliniques, Marseille, France; CEMEREM, Aix Marseille université, CNRS, CRMBM, UMR 7339, Marseille, France.
  • Colamarino R; Service de neurologie, CH d'Antibes, Antibes, France.
  • Ruet A; Service de neurologie pathologie inflammatoire du système nerveux central, CRC SEP, CHU Pellegrin, CHU de Bordeaux, Bordeaux, France; Inserm U1215, Neurocentre Magendie, université de Bordeaux, Bordeaux, France.
Rev Neurol (Paris) ; 2024 Jul 12.
Article em En | MEDLINE | ID: mdl-39003098
ABSTRACT
Cognitive impairment is one of the invisible symptoms of Multiple sclerosis (MS), which could be associated with depression, unemployment, reduced social interaction, inability to drive, and compromised quality of life. Moreover, the presence of cognitive impairment can be considered as a long-term prognostic factor and in the follow-up of disability. So, cognitive assessment is a crucial element in clinical follow-up of patients with MS (pwMS). International recommendations mention the use of the Brief International Cognitive Assessment in MS (BICAMS). The BICAMS, that has been recently validated in French is a brief non-exhaustive assessment, developed as a short screening battery, hence needing other supplemented tests. The present paper aims to propose a consensus, approved by expert French consensus from the Cognition group of the SF-SEP (http//sfsep.org [Société Francophone de la Sclérose en Plaques]), for cognitive assessment of pwMS suggesting the tools that should be used in order to apprehend the other cognitive impairments that could appear in MS.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Rev Neurol (Paris) Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Rev Neurol (Paris) Ano de publicação: 2024 Tipo de documento: Article